Literature DB >> 3153009

Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet.

J Brodehl1, A Krause, P F Hoyer.   

Abstract

It is well established that plasma phosphate (Pp) is largely determined by the renal phosphate threshold, which is best described by the maximal rate of tubular phosphate reabsorption divided by the glomerular filtration rate (Tmp/GFR). For its clinical assessment either direct phosphate loading with simultaneous measurement of GFR is performed, or the nomogram described by Walton and Bijvoet is used. In order to test the validity of the two methods, we compared in 20 infants and 31 children the fasting values of phosphate reabsorption [endogenous phosphate reabsorption/inulin clearance (Tp/Cin) and Tp] with those obtained after phosphate loading [maximal phosphate reabsorption (Tmp) and Tmp/Cin], and both with those derived from the nomogram. In addition the fasting Tp/Cin of 50 infants and 143 children could be compared with the nomogram. The results demonstrate that the directly measured Tp/Cin was the same as the directly measured Tmp/Cin and that the measured Tmp/Cin was correctly estimated by the nomogram. However, the comparison of fasting Tp/Cin with nomogram-derived values showed a systematic error, by which the latter values were higher than those measured. The discrepancy was due to the splay of the phosphate titration curve, which was found by Bijvoet when the ratio of phosphate clearance (Cp) corrected for GFR (Cp/GFR) fell below 0.2. The incorporation of this splay in the nomogram could not be confirmed by data measured in our children. It is concluded that fasting Tp is already "maximal" and that, therefore, no phosphate loading is necessary to estimate Tmp. Furthermore, there is no evidence of a major splay, which makes the nomogram incompatible below a Cp/GFR ratio of 0.2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3153009     DOI: 10.1007/bf00862587

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  A method for estimating Tm for phosphate in man.

Authors:  J ANDERSON
Journal:  J Physiol       Date:  1955-11-28       Impact factor: 5.182

2.  THE RENAL REGULATION OF ACID-BASE BALANCE IN MAN. II. FACTORS AFFECTING THE EXCRETION OF TITRATABLE ACID BY THE NORMAL HUMAN SUBJECT.

Authors:  W A Schiess; J L Ayer; W D Lotspeich; R F Pitts; P Miner
Journal:  J Clin Invest       Date:  1948-01       Impact factor: 14.808

3.  A photometric method for the determination of insulin in plasma and urine.

Authors:  J H ROE; J H EPSTEIN; N P GOLDSTEIN
Journal:  J Biol Chem       Date:  1949-04       Impact factor: 5.157

4.  [Influence of phosphate load on renal amino-acid transport].

Authors:  H P Weber; J Brodehl; A Jäkel
Journal:  Monatsschr Kinderheilkd       Date:  1973-07

5.  Growth and renal control of plasma phosphate.

Authors:  J Corvilain; M Abramow
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

6.  The assessment of phosphate reabsorption.

Authors:  O L Bijvoet; D B Morgan; P Fourman
Journal:  Clin Chim Acta       Date:  1969-10       Impact factor: 3.786

7.  Hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  M Tieder; D Modai; R Samuel; R Arie; A Halabe; I Bab; D Gabizon; U A Liberman
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

8.  Developmental patterns of renal functional maturation compared in the human neonate.

Authors:  B S Arant
Journal:  J Pediatr       Date:  1978-05       Impact factor: 4.406

9.  Direct measurement of TP/GFR: a simple and reliable parameter of renal phosphate handling.

Authors:  H Stark; B Eisenstein; M Tieder; A Rachmel; G Alpert
Journal:  Nephron       Date:  1986       Impact factor: 2.847

10.  Postnatal development of tubular phosphate reabsorption.

Authors:  J Brodehl; K Gellissen; H P Weber
Journal:  Clin Nephrol       Date:  1982-04       Impact factor: 0.975

View more
  26 in total

1.  Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.

Authors:  Andreas H Groll; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Raul M Alfaro; Christine King; Stephen C Piscitelli; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

2.  Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: long-term follow-up in one kindred.

Authors:  Y Yu; S R Sanderson; M Reyes; A Sharma; N Dunbar; T Srivastava; H Jüppner; C Bergwitz
Journal:  Bone       Date:  2012-02-24       Impact factor: 4.398

Review 3.  Clinical practice: diagnostic approach to the rachitic child.

Authors:  Jaishen Rajah; Kebashni Thandrayen; John M Pettifor
Journal:  Eur J Pediatr       Date:  2011-07-21       Impact factor: 3.183

4.  Hypophosphatemic rickets: results of a long-term follow-up.

Authors:  Maria Helena Vaisbich; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

5.  Ifosfamide nephrotoxicity in paediatric cancer patients.

Authors:  M S Ashraf; J Brady; F Breatnach; P F Deasy; A O'Meara
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

Review 6.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy.

Authors:  Frank Rutsch; Petra Böyer; Yvonne Nitschke; Nico Ruf; Bettina Lorenz-Depierieux; Tanja Wittkampf; Gabriele Weissen-Plenz; Rudolf-Josef Fischer; Zulf Mughal; John W Gregory; Justin H Davies; Chantal Loirat; Tim M Strom; Dirk Schnabel; Peter Nürnberg; Robert Terkeltaub
Journal:  Circ Cardiovasc Genet       Date:  2008-12

Review 8.  Post-renal transplantation hypophosphatemia.

Authors:  Khashayar Sakhaee
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

9.  Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour.

Authors:  A R M Radaideh; D Jaradat; M M Abu-Kalaf; M K Nusier
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

Review 10.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.